Jazz Gets Second Indication For Xywav As First Therapy For Idiopathic Hypersomnia

 
• By Joseph Haas
  
Red Approved Stamp with Wooden handle Rubber Stamper Isolated on White Background.
Jazz's second indication for Xywav is also the first approval in idiopathic hypersomnia
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip